Revenue, last quarter
$22.8M
+6.2% vs same quarter last year
Net income
−$8.4M
+39.9% vs same quarter last year
EPS, diluted
−$0.19
+44.1% vs same quarter last year
Operating cash flow
−$3.2M
+61% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $90.5M | −$54M |
| FY24 | $83.8M | −$56.4M |
| FY23 | $68.7M | −$60.8M |
| FY22 | $53.7M | −$58.9M |
| FY21 | $48.4M | −$48.7M |
| FY20 | $32.7M | −$32.2M |
| FY19 | $32.6M | −$20.7M |
| FY18 | $20M | −$18.5M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 74.2% | −59.3% | −59.7% |
| FY24 | 74% | −68.9% | −67.3% |
| FY23 | 73.9% | −90.2% | −88.6% |
| FY22 | 74.3% | −109.3% | −109.8% |
| FY21 | 73.6% | −97.7% | −100.5% |
| FY20 | 64.8% | −98.8% | −98.5% |
| FY19 | 68.8% | −54.7% | −63.5% |
| FY18 | 61.4% | −75.2% | −92.4% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$32.8M |
| FY24 | −$33M |
| FY23 | −$38.4M |
| FY22 | −$46.4M |
| FY21 | −$45.1M |
| FY20 | −$31.5M |
| FY19 | −$21.5M |
| FY18 | −$18.7M |
| FY17 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | $0 |
| FY22 | $27K |
| FY21 | $26K |
| FY20 | $21K |
| FY19 | $12K |
| FY18 | $0 |
| FY17 | - |
- Pulmonx
- Healthcare median
Show the numbers
| Year | Pulmonx | Healthcare median |
|---|---|---|
| FY25 | −59.7% | −30.6% |
| FY24 | −67.3% | −47% |
| FY23 | −88.6% | −58% |
| FY22 | −109.8% | −80.4% |
| FY21 | −100.5% | −71.8% |
| FY20 | −98.5% | −62.2% |
| FY19 | −63.5% | −46.2% |
| FY18 | −92.4% | −49.6% |
| FY17 | - | −45.9% |